Home/Helicore Biopharma/Klaus Veitinger, MD, PhD
KV

Klaus Veitinger, MD, PhD

Executive Chair

Helicore Biopharma

Therapeutic Areas

Helicore Biopharma Pipeline

DrugIndicationPhase
GIP-neutralizing antibodyObesityPre-clinical